[
    "{\"step_by_step_thinking\": \"Document 0 clearly states that the CRISPR-Cas12a system was used to detect circulating EGFR mutations in plasma. The study demonstrated that the system could rapidly and sensitively detect these mutations, suggesting potential prognostic or therapeutic implications.\", \"answer_choice\": \"A\"}"
]